Scientific Research Publishing12d
Quality of Life of Patients Followed for Common Low Back Pain: A Case-Control Study ()
Introduction: Common low-back pain is a frequent reason for consultation and a genuine public health problem. Preserving ...
BioRestorative Therapies, Inc: BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting - - IND clearance expands Company's advanced clinical pipeline for ...
BioRestorative Announces FDA Clearance of IND for Phase 2 Trial of BRTX-100 in Chronic Cervical Discogenic Pain
BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting –– IND ...